Works matching IS 07248741 AND DT 2024 AND VI 41 AND IP 9
Results: 13
Retraction Note: Verapamil Inhibits Ser202/Thr205 Phosphorylation of Tau by Blocking TXNIP/ROS/p38 MAPK Pathway.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The Use of Systemically Absorbed Drugs to Explore An In Vitro Bioequivalence Approach For Comparing Non-Systemically Absorbed Active Pharmaceutical Ingredients in Drug Products For Use in Dogs.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1797, doi. 10.1007/s11095-024-03766-3
- By:
- Publication type:
- Article
Current Approaches to Design Space Development and Regulatory Applications for Drug Products: Findings from the IQ Utilization of Design Space for Filings Working Group Survey.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1775, doi. 10.1007/s11095-024-03765-4
- By:
- Publication type:
- Article
A Novel Size Exclusion Chromatography Method for the Analysis of Monoclonal Antibodies and Antibody–drug Conjugates by Using Sodium Iodide in the Mobile Phase.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1893, doi. 10.1007/s11095-024-03763-6
- By:
- Publication type:
- Article
MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1811, doi. 10.1007/s11095-024-03762-7
- By:
- Publication type:
- Article
Current Insights into CAR T-Cell-Based Therapies for Myelodysplastic Syndrome.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1757, doi. 10.1007/s11095-024-03761-8
- By:
- Publication type:
- Article
Correction: Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1881, doi. 10.1007/s11095-024-03759-2
- By:
- Publication type:
- Article
Rapid Synthesis and Evaluation of Resveratrol-Piperazine Cocrystals by Ultrasound and Microwave Methods.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1843, doi. 10.1007/s11095-024-03758-3
- By:
- Publication type:
- Article
Fecal SN-38 Content as a Surrogate Predictor of Intestinal SN-38 Exposure and Associated Irinotecan-induced Severe Delayed-Onset Diarrhea by a Novel Use of the Spectrofluorimetric Method.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1855, doi. 10.1007/s11095-024-03755-6
- By:
- Publication type:
- Article
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part II: In vivo Efficacy Testing in a Rabbit Surfactant Washout Model.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1827, doi. 10.1007/s11095-024-03754-7
- By:
- Publication type:
- Article
Formulation and Validation of an Extended Sigmoid Emax Model in Pharmacodynamics.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1787, doi. 10.1007/s11095-024-03752-9
- By:
- Publication type:
- Article
Acceleration of Final Residual Solvent Extraction From Poly(lactide-co-glycolide) Microparticles.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 9, p. 1869, doi. 10.1007/s11095-024-03744-9
- By:
- Publication type:
- Article